Learn More
Medchemexpress LLC Moexipril (hydrochloride) | 82586-52-5 | 98.4% | 25 MG

Supplier: Medchemexpress LLC 25MGHYB0378A
Moexipril hydrochloride is an orally active inhibitor of angiotensin-converting enzyme (ACE) that becomes effective after being hydrolyzed to moexiprilat (hydrochloride). This compound demonstrates significant antihypertensive and neuroprotective effects.
- Orally active inhibitor of angiotensin-converting enzyme (ACE).
- Becomes effective after hydrolysis to moexiprilat.
- Exhibits antihypertensive and neuroprotective effects.
- High potency against plasma ACE and purified ACE from rabbit lung.
- Significantly reduces damaged neurons in a dose-dependent manner.
- Attenuates Fe2+/3+-induced neurotoxicity.
- Does not cause significant changes in apoptotic neurons.
- Does not cross the blood-brain barrier.
- Shows dose-dependent antihypertensive effects in various animal models.
- Reduces infarct area on mouse brain surface.
- Attenuates cortical infarct volume in rat brain.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.